[TREATMENT OF DUPUYTREN'S DISEASE BY ISOLATED PHARMACODYNAMIC "EXERESIS" OR "EXERESIS" COMPLETED BY A SOLELY CUTANEOUS PLASTIC STEP].
D000279:Administration, Cutaneous; D002918:Chymotrypsin; D004357:Drug Synergism; D004387:Dupuytren Contracture; D005528:Foot; D006026:Glycoside Hydrolases; D006403:Hematologic Tests; D006801:Humans; D006821:Hyaluronoglucosaminidase; D008012:Lidocaine; D010969:Plastics; D013514:Surgical Procedures, Operative; D014357:Trypsin
D010969:Plastics; D008012:Lidocaine; D006026:Glycoside Hydrolases; D006821:Hyaluronoglucosaminidase; D002918:Chymotrypsin; D014357:Trypsin
CHYMOTRYPSIN; DRUG SYNERGISM; DUPUYTREN'S CONTRACTURE; GLYCOSIDE HYDROLASES; HYALURONIDASE; LIDOCAINE; SURGERY, OPERATIVE; TRYPSIN
TRAITEMENT DE LA MALADIE DE DUPUYTREN PAR "EX'ER'ESE" PHARMACO-DYNAMIQUE ISOL'EE OU COMPL'ET'EE PAR UN TEMPS PLASTIQUE UNIQUEMENT CUTAN'E.